+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Base Editing Market - Global Forecast to 2030- Product Image
Base Editing Market - Global Forecast to 2030- Product Image
New

Base Editing Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082454
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Base Editing Market grew from USD 319.93 million in 2024 to USD 373.66 million in 2025. It is expected to continue growing at a CAGR of 16.18%, reaching USD 786.79 million by 2030.

Base editing has emerged as a revolutionary genome engineering approach that enables precise conversion of individual DNA bases without inducing double-strand breaks. This technique leverages deaminase enzymes fused to catalytically impaired CRISPR-Cas proteins, allowing targeted cytosine-to-thymine or adenine-to-guanine substitutions. As the field bridges foundational research and real-world applications, stakeholders across agriculture, therapeutics, and industrial biotechnology face unprecedented opportunities to reshape genetic landscapes with enhanced safety and efficiency. This executive summary distills the critical developments shaping the base editing market today, highlights regulatory and trade dynamics, and delivers strategic insights to inform decision-makers navigating a rapidly evolving ecosystem.

Transformative Shifts Defining the Base Editing Landscape

Over the past five years, base editing has transitioned from proof-of-concept studies to tangible breakthroughs in crop and clinical pipelines. Improvements in enzyme specificity and reduced off-target activity have propelled adenine and cytosine base editors into applications ranging from nutrient fortification to disease correction. Academic groups and biotech startups are forging collaborations with pharmaceutical firms to accelerate preclinical validation, while contract research organizations integrate base editing protocols to expand service offerings. Concurrently, innovations in non-viral lipid nanoparticle and viral vector delivery have unlocked new ex vivo and in vivo modalities, broadening the technology’s reach. These converging trends are driving an inflection point where precision editing not only accelerates R&D timelines but also lowers safety barriers, catalyzing a shift toward routine deployment of base editors in both laboratory and field settings.

Analyzing the 2025 Tariff Impact on Base Editing Supply Chains in the United States

Beginning in early 2025, the United States implemented a series of escalating tariffs on imported reagents, specialized enzymes, and laboratory instrumentation pivotal to base editing workflows. The cumulative burden has driven up the cost of critical inputs by double-digit percentages, prompting academic centers and biotech innovators to reassess supply chains. In response, several organizations have initiated domestic manufacturing partnerships and localized reagent production to reduce exposure to import duties. Moreover, equipment vendors are reevaluating distribution networks and pricing models to maintain competitiveness. As a result, the industry is experiencing a redistribution of procurement practices, with higher-margin providers consolidating market share and regional hubs emerging to mitigate tariff-driven disruptions.

Key Segmentation Insights Across Application, End-User, Technology, Organism and Ethical Criteria

A granular segmentation analysis reveals distinct segments driving growth and adoption. When examining application types, agricultural endeavors encompass crop improvement efforts aimed at bolstering disease resistance, enhancing drought tolerance, insect resistance, and improved nutritional profiles-spanning mineral enrichment, elevated protein content and vitamin enhancement-while therapeutic pipelines prioritize blood disorder corrections, cardiovascular interventions, treatment of genetic disorders, neurodegenerative disease models and oncology targets. From the perspective of end-users, the market engages a spectrum of academic and research institutes that include government schools, private research organizations and universities, alongside biotechnology companies ranging from established enterprises to agile startups, contract research organizations expanding service portfolios and pharmaceutical firms focused on clinical research and drug development. Technological segmentation underscores the importance of base editor type distinctions between adenine and cytosine editors, delivery approach diversification through ex vivo cell and gene therapy, in vivo delivery and patient-targeted strategies, and vector selections spanning lipid nanoparticle-based non-viral systems, nuclear delivery platforms and viral vectors such as adeno-associated viruses and lentiviruses. Target organism segmentation highlights applications in animals-specifically aquaculture, livestock and poultry-humans and plants. Across these axes, ethical standards centering on patient safety, public acceptance and regulatory compliance shape adoption pathways, while market participants vary from emerging entrants and pioneering startups to major industry players and ongoing merger and acquisition activity.

Key Regional Insights Highlighting Market Drivers and Hurdles

Regional dynamics reveal unique drivers and barriers. In the Americas, robust funding infrastructures, leading academic centers and a concentration of biomanufacturing capacity fuel rapid base editing innovation. Europe, the Middle East & Africa exhibit cautious regulatory progress alongside growing public-private partnerships, with several national initiatives supporting translational research and field trials. Meanwhile, the Asia-Pacific region is characterized by substantial government incentives, expanding contract research networks and an emphasis on agricultural applications to support food security and sustainable farming, coupled with burgeoning investments in clinical gene editing programs.

Key Company Insights Showcasing Service Leaders and Innovators

The competitive landscape features a diverse array of specialized providers and integrated service leaders. Addgene, Inc. serves as a pivotal plasmid repository supporting widespread access to base editing constructs, while Beam Therapeutics pioneers next-generation precision editing therapies. Beijing Qi Biodesign Biotechnology Company Limited and Bio Palette Co., Ltd. are expanding reagent portfolios in Asia, and Creative Biogene alongside DH Life Sciences, LLC deliver tailored custom editing services. Editas Medicine, Inc. and Intellia Therapeutics, Inc. advance in vivo therapeutic candidates, and ElevateBio, LLC fosters scalable cell therapy manufacturing. GenScript Biotech Corporation reinforces gene synthesis and protein production capabilities, KromaTiD Inc. innovates quantitative assay technologies, and Pairwise Plants Services drives agricultural trait development. ProQR Therapeutics N.V. integrates RNA-based strategies with editing technologies, QIAGEN GmbH supplies sample preparation and bioinformatics solutions, Revvity, Inc. offers essential laboratory consumables and instrumentation, while Sangamo Therapeutics, Inc. synergizes zinc finger platforms with base editors. Synthego Corporation delivers synthetic guide RNA services, Tecan Group provides automation and workflow integration, and TriLink BioTechnologies by Maravai LifeSciences supplies critical modified nucleotides and mRNA components.

Actionable Recommendations for Industry Leaders to Accelerate Adoption and Mitigate Risks

For industry leaders seeking to harness base editing’s potential, several strategic actions are critical. First, investing in scalable and modular delivery platforms-particularly lipid nanoparticles and patient-targeted systems-will unlock broader application areas. Second, diversifying supply sources and establishing regional reagent production hubs can mitigate tariff and logistical risks. Third, fostering cross-sector alliances between academic institutions, biotech startups and pharmaceutical firms accelerates translational pipelines and resource sharing. Fourth, engaging regulatory bodies at early development stages ensures alignment on safety endpoints and streamlines approval pathways. Fifth, proactively addressing patient safety and public acceptance through transparent communication and ethical frameworks will reinforce societal trust. Lastly, integrating real-time data analytics into R&D workflows enhances decision-making and optimizes resource allocation across discovery and development stages.

Conclusion: Navigating the Intersection of Innovation, Regulation and Strategy

The maturation of base editing technologies signals a turning point in precision biology, with far-reaching implications across agriculture, human health and beyond. As tariff landscapes and regulatory environments evolve, stakeholders who adopt strategic sourcing, invest in delivery innovations and cultivate collaborative networks will secure competitive advantage. Ultimately, aligning technical expertise with ethical stewardship and proactive regulatory engagement will define the next wave of successful base editing applications.

Market Segmentation & Coverage

This research report categorizes the Base Editing Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Agricultural Applications
    • Crop Improvement
    • Disease Resistance
    • Drought Tolerance
    • Enhanced Nutritional Value
      • Minerals
      • Protein Content
      • Vitamins
    • Insect Resistance
  • Therapeutic Applications
    • Blood Disorders
    • Cardiovascular Diseases
    • Genetic Disorders
    • Neurodegenerative Diseases
    • Oncology
  • Academic & Research Institutes
    • Government Schools
    • Private Research Organizations
    • Universities
  • Biotechnology Companies
    • Established Enterprises
    • Startups
  • Contract Research Organizations (CROs)
  • Pharmaceutical Firms
    • Clinical Research
    • Drug Development
  • Base Editor Types
    • Adenine Base Editors
    • Cytosine Base Editors
  • Delivery Techniques
    • Ex Vivo Delivery
      • Cell Therapy
      • Gene Therapy
    • In Vivo Delivery
    • Patient Targeted Delivery
  • Vector Technologies
    • Non-Viral Vectors
      • Lipid Nanoparticles
    • Nuclear Delivery
    • Viral Vectors
      • Adeno-associated Viruses
      • Lentiviruses
  • Animals
    • Aquaculture
    • Livestock
    • Poultry
  • Humans
  • Plants
  • Patient Safety
  • Public Acceptance
  • Regulatory Compliance
  • Emerging Participants
  • Major Industry Players
  • Mergers & Acquisitions

This research report categorizes the Base Editing Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Base Editing Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Addgene, Inc.
  • Beam Therapeutics
  • Beijing Qi Biodesign Biotechnology Company Limited
  • Bio Palette Co., Ltd.
  • Creative Biogene
  • DH Life Sciences, LLC
  • Editas Medicine, Inc.
  • ElevateBio, LLC
  • GenScript Biotech Corporation
  • Intellia Therapeutics, Inc.
  • KromaTiD Inc.
  • Pairwise Plants Services
  • ProQR Therapeutics N.V.
  • QIAGEN GmbH
  • Revvity, Inc.
  • Sangamo Therapeutics, Inc.
  • Synthego Corporation
  • Tecan Group
  • TriLink BioTechnologies by Maravai LifeSciences

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Base Editing Market, by Application Type
8.1. Introduction
8.2. Agricultural Applications
8.2.1. Crop Improvement
8.2.2. Disease Resistance
8.2.3. Drought Tolerance
8.2.4. Enhanced Nutritional Value
8.2.4.1. Minerals
8.2.4.2. Protein Content
8.2.4.3. Vitamins
8.2.5. Insect Resistance
8.3. Therapeutic Applications
8.3.1. Blood Disorders
8.3.2. Cardiovascular Diseases
8.3.3. Genetic Disorders
8.3.4. Neurodegenerative Diseases
8.3.5. Oncology
9. Base Editing Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.2.1. Government Schools
9.2.2. Private Research Organizations
9.2.3. Universities
9.3. Biotechnology Companies
9.3.1. Established Enterprises
9.3.2. Startups
9.4. Contract Research Organizations (CROs)
9.5. Pharmaceutical Firms
9.5.1. Clinical Research
9.5.2. Drug Development
10. Base Editing Market, by Technology
10.1. Introduction
10.2. Base Editor Types
10.2.1. Adenine Base Editors
10.2.2. Cytosine Base Editors
10.3. Delivery Techniques
10.3.1. Ex Vivo Delivery
10.3.1.1. Cell Therapy
10.3.1.2. Gene Therapy
10.3.2. In Vivo Delivery
10.3.3. Patient Targeted Delivery
10.4. Vector Technologies
10.4.1. Non-Viral Vectors
10.4.1.1. Lipid Nanoparticles
10.4.2. Nuclear Delivery
10.4.3. Viral Vectors
10.4.3.1. Adeno-associated Viruses
10.4.3.2. Lentiviruses
11. Base Editing Market, by Target Organism
11.1. Introduction
11.2. Animals
11.2.1. Aquaculture
11.2.2. Livestock
11.2.3. Poultry
11.3. Humans
11.4. Plants
12. Base Editing Market, by Ethical Standards
12.1. Introduction
12.2. Patient Safety
12.3. Public Acceptance
12.4. Regulatory Compliance
13. Base Editing Market, by Market Participants
13.1. Introduction
13.2. Emerging Participants
13.3. Major Industry Players
13.4. Mergers & Acquisitions
14. Americas Base Editing Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Base Editing Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Base Editing Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Addgene, Inc.
17.3.2. Beam Therapeutics
17.3.3. Beijing Qi Biodesign Biotechnology Company Limited
17.3.4. Bio Palette Co., Ltd.
17.3.5. Creative Biogene
17.3.6. DH Life Sciences, LLC
17.3.7. Editas Medicine, Inc.
17.3.8. ElevateBio, LLC
17.3.9. GenScript Biotech Corporation
17.3.10. Intellia Therapeutics, Inc.
17.3.11. KromaTiD Inc.
17.3.12. Pairwise Plants Services
17.3.13. ProQR Therapeutics N.V.
17.3.14. QIAGEN GmbH
17.3.15. Revvity, Inc.
17.3.16. Sangamo Therapeutics, Inc.
17.3.17. Synthego Corporation
17.3.18. Tecan Group
17.3.19. TriLink BioTechnologies by Maravai LifeSciences
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BASE EDITING MARKET MULTI-CURRENCY
FIGURE 2. BASE EDITING MARKET MULTI-LANGUAGE
FIGURE 3. BASE EDITING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BASE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BASE EDITING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BASE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BASE EDITING MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BASE EDITING MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BASE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BASE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BASE EDITING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BASE EDITING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BASE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BASE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BASE EDITING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BASE EDITING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BASE EDITING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BASE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BASE EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BASE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BASE EDITING MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BASE EDITING MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BASE EDITING MARKET SIZE, BY DROUGHT TOLERANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BASE EDITING MARKET SIZE, BY MINERALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BASE EDITING MARKET SIZE, BY PROTEIN CONTENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BASE EDITING MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BASE EDITING MARKET SIZE, BY INSECT RESISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BASE EDITING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BASE EDITING MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BASE EDITING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BASE EDITING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BASE EDITING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BASE EDITING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BASE EDITING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BASE EDITING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BASE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BASE EDITING MARKET SIZE, BY GOVERNMENT SCHOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BASE EDITING MARKET SIZE, BY PRIVATE RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BASE EDITING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BASE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BASE EDITING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BASE EDITING MARKET SIZE, BY ESTABLISHED ENTERPRISES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BASE EDITING MARKET SIZE, BY STARTUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BASE EDITING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BASE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BASE EDITING MARKET SIZE, BY PHARMACEUTICAL FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BASE EDITING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BASE EDITING MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BASE EDITING MARKET SIZE, BY PHARMACEUTICAL FIRMS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BASE EDITING MARKET SIZE, BY BASE EDITOR TYPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BASE EDITING MARKET SIZE, BY ADENINE BASE EDITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BASE EDITING MARKET SIZE, BY CYTOSINE BASE EDITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BASE EDITING MARKET SIZE, BY BASE EDITOR TYPES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BASE EDITING MARKET SIZE, BY DELIVERY TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BASE EDITING MARKET SIZE, BY EX VIVO DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BASE EDITING MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BASE EDITING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BASE EDITING MARKET SIZE, BY EX VIVO DELIVERY, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BASE EDITING MARKET SIZE, BY IN VIVO DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BASE EDITING MARKET SIZE, BY PATIENT TARGETED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BASE EDITING MARKET SIZE, BY DELIVERY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BASE EDITING MARKET SIZE, BY VECTOR TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BASE EDITING MARKET SIZE, BY NON-VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BASE EDITING MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BASE EDITING MARKET SIZE, BY NON-VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BASE EDITING MARKET SIZE, BY NUCLEAR DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BASE EDITING MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BASE EDITING MARKET SIZE, BY ADENO-ASSOCIATED VIRUSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BASE EDITING MARKET SIZE, BY LENTIVIRUSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BASE EDITING MARKET SIZE, BY VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BASE EDITING MARKET SIZE, BY VECTOR TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BASE EDITING MARKET SIZE, BY ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BASE EDITING MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BASE EDITING MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BASE EDITING MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BASE EDITING MARKET SIZE, BY ANIMALS, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BASE EDITING MARKET SIZE, BY HUMANS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BASE EDITING MARKET SIZE, BY PLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BASE EDITING MARKET SIZE, BY PATIENT SAFETY, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BASE EDITING MARKET SIZE, BY PUBLIC ACCEPTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BASE EDITING MARKET SIZE, BY REGULATORY COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BASE EDITING MARKET SIZE, BY EMERGING PARTICIPANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BASE EDITING MARKET SIZE, BY MAJOR INDUSTRY PLAYERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BASE EDITING MARKET SIZE, BY MERGERS & ACQUISITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS BASE EDITING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS BASE EDITING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS BASE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS BASE EDITING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS BASE EDITING MARKET SIZE, BY PHARMACEUTICAL FIRMS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS BASE EDITING MARKET SIZE, BY BASE EDITOR TYPES, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS BASE EDITING MARKET SIZE, BY DELIVERY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS BASE EDITING MARKET SIZE, BY EX VIVO DELIVERY, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS BASE EDITING MARKET SIZE, BY VECTOR TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS BASE EDITING MARKET SIZE, BY NON-VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS BASE EDITING MARKET SIZE, BY VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS BASE EDITING MARKET SIZE, BY ANIMALS, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS BASE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA BASE EDITING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA BASE EDITING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA BASE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA BASE EDITING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA BASE EDITING MARKET SIZE, BY PHARMACEUTICAL FIRMS, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA BASE EDITING MARKET SIZE, BY BASE EDITOR TYPES, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA BASE EDITING MARKET SIZE, BY DELIVERY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA BASE EDITING MARKET SIZE, BY EX VIVO DELIVERY, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA BASE EDITING MARKET SIZE, BY VECTOR TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA BASE EDITING MARKET SIZE, BY NON-VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA BASE EDITING MARKET SIZE, BY VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA BASE EDITING MARKET SIZE, BY ANIMALS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL BASE EDITING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL BASE EDITING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL BASE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL BASE EDITING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL BASE EDITING MARKET SIZE, BY PHARMACEUTICAL FIRMS, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL BASE EDITING MARKET SIZE, BY BASE EDITOR TYPES, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL BASE EDITING MARKET SIZE, BY DELIVERY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL BASE EDITING MARKET SIZE, BY EX VIVO DELIVERY, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL BASE EDITING MARKET SIZE, BY VECTOR TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL BASE EDITING MARKET SIZE, BY NON-VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL BASE EDITING MARKET SIZE, BY VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL BASE EDITING MARKET SIZE, BY ANIMALS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2018-2030 (USD MILLION)
TABLE 137. CANADA BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 138. CANADA BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 139. CANADA BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, 2018-2030 (USD MILLION)
TABLE 140. CANADA BASE EDITING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 141. CANADA BASE EDITING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. CANADA BASE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 143. CANADA BASE EDITING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 144. CANADA BASE EDITING MARKET SIZE, BY PHARMACEUTICAL FIRMS, 2018-2030 (USD MILLION)
TABLE 145. CANADA BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. CANADA BASE EDITING MARKET SIZE, BY BASE EDITOR TYPES, 2018-2030 (USD MILLION)
TABLE 147. CANADA BASE EDITING MARKET SIZE, BY DELIVERY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 148. CANADA BASE EDITING MARKET SIZE, BY EX VIVO DELIVERY, 2018-2030 (USD MILLION)
TABLE 149. CANADA BASE EDITING MARKET SIZE, BY VECTOR TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 150. CANADA BASE EDITING MARKET SIZE, BY NON-VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 151. CANADA BASE EDITING MARKET SIZE, BY VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 152. CANADA BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2018-2030 (USD MILLION)
TABLE 153. CANADA BASE EDITING MARKET SIZE, BY ANIMALS, 2018-2030 (USD MILLION)
TABLE 154. CANADA BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2018-2030 (USD MILLION)
TABLE 155. CANADA BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2018-2030 (USD MILLION)
TABLE 156. MEXICO BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 157. MEXICO BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 158. MEXICO BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, 2018-2030 (USD MILLION)
TABLE 159. MEXICO BASE EDITING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 160. MEXICO BASE EDITING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. MEXICO BASE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 162. MEXICO BASE EDITING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 163. MEXICO BASE EDITING MARKET SIZE, BY PHARMACEUTICAL FIRMS, 2018-2030 (USD MILLION)
TABLE 164. MEXICO BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. MEXICO BASE EDITING MARKET SIZE, BY BASE EDITOR TYPES, 2018-2030 (USD MILLION)
TABLE 166. MEXICO BASE EDITING MARKET SIZE, BY DELIVERY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 167. MEXICO BASE EDITING MARKET SIZE, BY EX VIVO DELIVERY, 2018-2030 (USD MILLION)
TABLE 168. MEXICO BASE EDITING MARKET SIZE, BY VECTOR TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 169. MEXICO BASE EDITING MARKET SIZE, BY NON-VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 170. MEXICO BASE EDITING MARKET SIZE, BY VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 171. MEXICO BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2018-2030 (USD MILLION)
TABLE 172. MEXICO BASE EDITING MARKET SIZE, BY ANIMALS, 2018-2030 (USD MILLION)
TABLE 173. MEXICO BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2018-2030 (USD MILLION)
TABLE 174. MEXICO BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES BASE EDITING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES BASE EDITING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES BASE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES BASE EDITING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES BASE EDITING MARKET SIZE, BY PHARMACEUTICAL FIRMS, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES BASE EDITING MARKET SIZE, BY BASE EDITOR TYPES, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES BASE EDITING MARKET SIZE, BY DELIVERY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES BASE EDITING MARKET SIZE, BY EX VIVO DELIVERY, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES BASE EDITING MARKET SIZE, BY VECTOR TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES BASE EDITING MARKET SIZE, BY NON-VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES BASE EDITING MARKET SIZE, BY VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES BASE EDITING MARKET SIZE, BY ANIMALS, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES BASE EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY PHARMACEUTICAL FIRMS, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY BASE EDITOR TYPES, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY DELIVERY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY EX VIVO DELIVERY, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY VECTOR TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY NON-VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY ANIMALS, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC BASE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA BASE EDITING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA BASE EDITING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA BASE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA BASE EDITING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA BASE EDITING MARKET SIZE, BY PHARMACEUTICAL FIRMS, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA BASE EDITING MARKET SIZE, BY BASE EDITOR TYPES, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA BASE EDITING MARKET SIZE, BY DELIVERY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA BASE EDITING MARKET SIZE, BY EX VIVO DELIVERY, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA BASE EDITING MARKET SIZE, BY VECTOR TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA BASE EDITING MARKET SIZE, BY NON-VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA BASE EDITING MARKET SIZE, BY VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA BASE EDITING MARKET SIZE, BY ANIMALS, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2018-2030 (USD MILLION)
TABLE 234. CHINA BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 235. CHINA BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 236. CHINA BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, 2018-2030 (USD MILLION)
TABLE 237. CHINA BASE EDITING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 238. CHINA BASE EDITING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. CHINA BASE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 240. CHINA BASE EDITING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 241. CHINA BASE EDITING MARKET SIZE, BY PHARMACEUTICAL FIRMS, 2018-2030 (USD MILLION)
TABLE 242. CHINA BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. CHINA BASE EDITING MARKET SIZE, BY BASE EDITOR TYPES, 2018-2030 (USD MILLION)
TABLE 244. CHINA BASE EDITING MARKET SIZE, BY DELIVERY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 245. CHINA BASE EDITING MARKET SIZE, BY EX VIVO DELIVERY, 2018-2030 (USD MILLION)
TABLE 246. CHINA BASE EDITING MARKET SIZE, BY VECTOR TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 247. CHINA BASE EDITING MARKET SIZE, BY NON-VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 248. CHINA BASE EDITING MARKET SIZE, BY VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 249. CHINA BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2018-2030 (USD MILLION)
TABLE 250. CHINA BASE EDITING MARKET SIZE, BY ANIMALS, 2018-2030 (USD MILLION)
TABLE 251. CHINA BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2018-2030 (USD MILLION)
TABLE 252. CHINA BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2018-2030 (USD MILLION)
TABLE 253. INDIA BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 254. INDIA BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 255. INDIA BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, 2018-2030 (USD MILLION)
TABLE 256. INDIA BASE EDITING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 257. INDIA BASE EDITING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 258. INDIA BASE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 259. INDIA BASE EDITING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 260. INDIA BASE EDITING MARKET SIZE, BY PHARMACEUTICAL FIRMS, 2018-2030 (USD MILLION)
TABLE 261. INDIA BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. INDIA BASE EDITING MARKET SIZE, BY BASE EDITOR TYPES, 2018-2030 (USD MILLION)
TABLE 263. INDIA BASE EDITING MARKET SIZE, BY DELIVERY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 264. INDIA BASE EDITING MARKET SIZE, BY EX VIVO DELIVERY, 2018-2030 (USD MILLION)
TABLE 265. INDIA BASE EDITING MARKET SIZE, BY VECTOR TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 266. INDIA BASE EDITING MARKET SIZE, BY NON-VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 267. INDIA BASE EDITING MARKET SIZE, BY VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 268. INDIA BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2018-2030 (USD MILLION)
TABLE 269. INDIA BASE EDITING MARKET SIZE, BY ANIMALS, 2018-2030 (USD MILLION)
TABLE 270. INDIA BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2018-2030 (USD MILLION)
TABLE 271. INDIA BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2018-2030 (USD MILLION)
TABLE 272. INDONESIA BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA BASE EDITING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA BASE EDITING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA BASE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA BASE EDITING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA BASE EDITING MARKET SIZE, BY PHARMACEUTICAL FIRMS, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA BASE EDITING MARKET SIZE, BY BASE EDITOR TYPES, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA BASE EDITING MARKET SIZE, BY DELIVERY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA BASE EDITING MARKET SIZE, BY EX VIVO DELIVERY, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA BASE EDITING MARKET SIZE, BY VECTOR TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA BASE EDITING MARKET SIZE, BY NON-VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA BASE EDITING MARKET SIZE, BY VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 287. INDONESIA BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2018-2030 (USD MILLION)
TABLE 288. INDONESIA BASE EDITING MARKET SIZE, BY ANIMALS, 2018-2030 (USD MILLION)
TABLE 289. INDONESIA BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2018-2030 (USD MILLION)
TABLE 290. INDONESIA BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2018-2030 (USD MILLION)
TABLE 291. JAPAN BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 292. JAPAN BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 293. JAPAN BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, 2018-2030 (USD MILLION)
TABLE 294. JAPAN BASE EDITING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 295. JAPAN BASE EDITING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 296. JAPAN BASE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 297. JAPAN BASE EDITING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 298. JAPAN BASE EDITING MARKET SIZE, BY PHARMACEUTICAL FIRMS, 2018-2030 (USD MILLION)
TABLE 299. JAPAN BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. JAPAN BASE EDITING MARKET SIZE, BY BASE EDITOR TYPES, 2018-2030 (USD MILLION)
TABLE 301. JAPAN BASE EDITING MARKET SIZE, BY DELIVERY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 302. JAPAN BASE EDITING MARKET SIZE, BY EX VIVO DELIVERY, 2018-2030 (USD MILLION)
TABLE 303. JAPAN BASE EDITING MARKET SIZE, BY VECTOR TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 304. JAPAN BASE EDITING MARKET SIZE, BY NON-VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 305. JAPAN BASE EDITING MARKET SIZE, BY VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 306. JAPAN BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2018-2030 (USD MILLION)
TABLE 307. JAPAN BASE EDITING MARKET SIZE, BY ANIMALS, 2018-2030 (USD MILLION)
TABLE 308. JAPAN BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2018-2030 (USD MILLION)
TABLE 309. JAPAN BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2018-2030 (USD MILLION)
TABLE 310. MALAYSIA BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 311. MALAYSIA BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 312. MALAYSIA BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, 2018-2030 (USD MILLION)
TABLE 313. MALAYSIA BASE EDITING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 314. MALAYSIA BASE EDITING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 315. MALAYSIA BASE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 316. MALAYSIA BASE EDITING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 317. MALAYSIA BASE EDITING MARKET SIZE, BY PHARMACEUTICAL FIRMS, 2018-2030 (USD MILLION)
TABLE 318. MALAYSIA BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 319. MALAYSIA BASE EDITING MARKET SIZE, BY BASE EDITOR TYPES, 2018-2030 (USD MILLION)
TABLE 320. MALAYSIA BASE EDITING MARKET SIZE, BY DELIVERY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 321. MALAYSIA BASE EDITING MARKET SIZE, BY EX VIVO DELIVERY, 2018-2030 (USD MILLION)
TABLE 322. MALAYSIA BASE EDITING MARKET SIZE, BY VECTOR TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 323. MALAYSIA BASE EDITING MARKET SIZE, BY NON-VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 324. MALAYSIA BASE EDITING MARKET SIZE, BY VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 325. MALAYSIA BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2018-2030 (USD MILLION)
TABLE 326. MALAYSIA BASE EDITING MARKET SIZE, BY ANIMALS, 2018-2030 (USD MILLION)
TABLE 327. MALAYSIA BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2018-2030 (USD MILLION)
TABLE 328. MALAYSIA BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES BASE EDITING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES BASE EDITING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES BASE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES BASE EDITING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES BASE EDITING MARKET SIZE, BY PHARMACEUTICAL FIRMS, 2018-2030 (USD MILLION)
TABLE 337. PHILIPPINES BASE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 338. PHILIPPINES BASE EDITING MARKET SIZE, BY BASE EDITOR TYPES, 2018-2030 (USD MILLION)
TABLE 339. PHILIPPINES BASE EDITING MARKET SIZE, BY DELIVERY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 340. PHILIPPINES BASE EDITING MARKET SIZE, BY EX VIVO DELIVERY, 2018-2030 (USD MILLION)
TABLE 341. PHILIPPINES BASE EDITING MARKET SIZE, BY VECTOR TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 342. PHILIPPINES BASE EDITING MARKET SIZE, BY NON-VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 343. PHILIPPINES BASE EDITING MARKET SIZE, BY VIRAL VECTORS, 2018-2030 (USD MILLION)
TABLE 344. PHILIPPINES BASE EDITING MARKET SIZE, BY TARGET ORGANISM, 2018-2030 (USD MILLION)
TABLE 345. PHILIPPINES BASE EDITING MARKET SIZE, BY ANIMALS, 2018-2030 (USD MILLION)
TABLE 346. PHILIPPINES BASE EDITING MARKET SIZE, BY ETHICAL STANDARDS, 2018-2030 (USD MILLION)
TABLE 347. PHILIPPINES BASE EDITING MARKET SIZE, BY MARKET PARTICIPANTS, 2018-2030 (USD MILLION)
TABLE 348. SINGAPORE BASE EDITING MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 349. SINGAPORE BASE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 350. SINGAPORE BASE EDITING MARKET SIZE, BY ENHANCED NUTRITIONAL VALUE, 2018-2030 (USD MILLION)
TABLE 351. SINGAPORE BASE EDITING MARKET SIZE, BY THERAPEUT

Companies Mentioned

  • Addgene, Inc.
  • Beam Therapeutics
  • Beijing Qi Biodesign Biotechnology Company Limited
  • Bio Palette Co., Ltd.
  • Creative Biogene
  • DH Life Sciences, LLC
  • Editas Medicine, Inc.
  • ElevateBio, LLC
  • GenScript Biotech Corporation
  • Intellia Therapeutics, Inc.
  • KromaTiD Inc.
  • Pairwise Plants Services
  • ProQR Therapeutics N.V.
  • QIAGEN GmbH
  • Revvity, Inc.
  • Sangamo Therapeutics, Inc.
  • Synthego Corporation
  • Tecan Group
  • TriLink BioTechnologies by Maravai LifeSciences

Methodology

Loading
LOADING...

Related Topics

Related Reports

Gene Editing Market by Technology, Application, End User, Product & Service, Delivery Method - Global Forecast 2025-2030 - Product Image

Gene Editing Market by Technology, Application, End User, Product & Service, Delivery Method - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9), Delivery Method (Ex Vivo), Application (Genetic Engineering, Clinical Applications), Mode (Contract, in-house), End Use, Region, with Growth Forecasts, 2025-2030 - Product Image

Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9), Delivery Method (Ex Vivo), Application (Genetic Engineering, Clinical Applications), Mode (Contract, in-house), End Use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Base Editing Market Size, Share & Trends Analysis Report By Product & Services (Platform, gRNA Design), By Application (Drug Discovery & DevelopmentAgriculture, Veterinary), By Type, By End-u-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Base Editing Market Size, Share & Trends Analysis Report By Product & Services (Platform, gRNA Design), By Application (Drug Discovery & DevelopmentAgriculture, Veterinary), By Type, By End-u-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Gene Therapy Market, 6th Edition: Industry Trends and Global Forecasts to 2035 - Therapeutic Area, Type of Vector, Type of Therapy, Type of Gene Delivery Method, Route of Administration, Geographical Region, Leading Market Players and Sales Forecast - Product Image

Gene Therapy Market, 6th Edition: Industry Trends and Global Forecasts to 2035 - Therapeutic Area, Type of Vector, Type of Therapy, Type of Gene Delivery Method, Route of Administration, Geographical Region, Leading Market Players and Sales Forecast

  • Report
  • 972 Pages
  • Global
From

About the Base Editing Market

In biotechnology, the Base Editing market encompasses the tools, services, and research activities related to the technology of base editing, which is a form of genome editing. Unlike broader methods such as CRISPR-Cas9, which induce double-strand breaks to create knockouts or insert new DNA sequences, base editing allows for the direct, irreversible conversion of one DNA base into another, without inducing double-strand breaks, thereby potentially reducing unintended edits or insertions. This precision technology can be applied in therapeutic settings, agriculture biotechnology, and research that requires single-nucleotide polymorphism. The market includes the development and sale of base editing components like engineered nucleases and guide RNA constructs, licensing of technologies, and the provision of services such as custom base editing and consulting. Companies and academic institutions in this field continuously engage in collaboration and intellectual property agreements to advance the technology and expand its application spectrum. Prominent participants in the base editing market include Beam Therapeutics, which specializes in developing precision genetic medicines using base editing, and CRISPR Therapeutics, which engages in gene-based treatments, including those involving novel gene-editing approaches. Other notable entities are Intellia Therapeutics and Editas Medicine, which are invested in the therapeutic application of genome editing technologies. These companies represent key innovators and market leaders, driving forward the applications and capabilities of base editing within the biotechnology sector. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.